In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Shares of Scholar Rock (SRRK) soared 16% on Wednesday after the company announced that its investigational drug Apitegromab, ...

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. Tirzepatide is less expensive and may be more effective. However, the drug is still new, and more research is needed.

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...

For adults struggling with weight, a weekly injection of tirzepatide offers ... reveal that the drug leads to significant and lasting weight loss over three years. This could change how healthcare ...

Tirzepatide 10 mg and 15 mg and semaglutide 2.4 mg outperformed other drugs for weight-loss efficacy ... with the 15 mg dose (SUCRA = 0.848), 10 mg dose (SUCRA = 0.841) and 5 mg dose (SUCRA ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs ... They commonly occurred as the treatment dose was being increased.

Drug giant Eli Lilly says its weight-loss drug tirzepatide helps people with obesity avoid getting diabetes, even months after stopping the medication. Excess weight increases the risk for ...

Dr. Aronne led a study showing that a 72-week course of tirzepatide at its maximum dosage reduced body weight by 20.9%; a similar study published in 2021 reported a 14.9% loss with semaglutide ...

CHICAGO — ­New clinical trial results on the diabetes and obesity drug ... drugs, tirzepatide is sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss).